{"id":"https://openalex.org/W2019615858","doi":"https://doi.org/10.1053/j.seminoncol.2011.01.014","title":"Pharmacokinetics and Pharmacodynamics of Nilotinib in Gastrointestinal Stromal Tumors","display_name":"Pharmacokinetics and Pharmacodynamics of Nilotinib in Gastrointestinal Stromal Tumors","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2019615858","doi":"https://doi.org/10.1053/j.seminoncol.2011.01.014","mag":"2019615858","pmid":"https://pubmed.ncbi.nlm.nih.gov/21419933"},"language":"en","primary_location":{"id":"doi:10.1053/j.seminoncol.2011.01.014","doi":"https://doi.org/10.1053/j.seminoncol.2011.01.014","is_oa":false,"landing_page_url":"https://doi.org/10.1053/j.seminoncol.2011.01.014","pdf_url":null,"source":{"id":"https://openalex.org/S77180905","display_name":"Seminars in Oncology","issn_l":"0093-7754","issn":["0093-7754","1532-8708"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004418792","display_name":"Jonathan C. Trent","orcid":"https://orcid.org/0000-0001-6169-5238","observed_orcids":["https://orcid.org/0000-0001-6169-5238"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jonathan Trent","raw_affiliation_strings":["Department of Sarcoma Medical Oncology and The Adult Sarcoma Research Center, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. jtrent@mdanderson.org","Department of Sarcoma Medical Oncology and The Adult Sarcoma Research Center, University of Texas M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Sarcoma Medical Oncology and The Adult Sarcoma Research Center, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. jtrent@mdanderson.org","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Sarcoma Medical Oncology and The Adult Sarcoma Research Center, University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078220154","display_name":"Mathi\u00e9u Molimard","orcid":"https://orcid.org/0000-0002-4346-8346","observed_orcids":["https://orcid.org/0000-0002-4346-8346"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mathieu Molimard","raw_affiliation_strings":["D\u00e9partement Hospitalo-Universitaire de Pharmacologie and Universit\u00e9 de Bordeaux, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement Hospitalo-Universitaire de Pharmacologie and Universit\u00e9 de Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004418792"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":1.5603,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.83971587,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"38","issue":null,"first_page":"S28","last_page":"S33"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":1.0},{"id":"https://openalex.org/keywords/gastrointestinal-stromal-tumor","display_name":"gastrointestinal stromal tumor","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9620000123977661},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/kit-inhibition","display_name":"KIT inhibition","score":0.9070000052452087},{"id":"https://openalex.org/keywords/pdgfr","display_name":"PDGFR","score":0.8230000138282776},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.9309999942779541},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9480000138282776},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7080000042915344},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.546999990940094},{"id":"https://openalex.org/keywords/proton-pump-inhibitors","display_name":"proton pump inhibitors","score":0.7919999957084656},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.6690000295639038},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.3019999861717224}],"concepts":[{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.9886772036552429},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8421674966812134},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7921929359436035},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.6614015102386475},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6496405005455017},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6173864603042603},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5786120891571045},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5639373660087585},{"id":"https://openalex.org/C2775922572","wikidata":"https://www.wikidata.org/wiki/Q83567","display_name":"GiST","level":3,"score":0.4206576943397522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3716357946395874},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.20032855868339539},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1932011842727661},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.16531997919082642}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046152","descriptor_name":"Gastrointestinal Stromal Tumors","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1053/j.seminoncol.2011.01.014","doi":"https://doi.org/10.1053/j.seminoncol.2011.01.014","is_oa":false,"landing_page_url":"https://doi.org/10.1053/j.seminoncol.2011.01.014","pdf_url":null,"source":{"id":"https://openalex.org/S77180905","display_name":"Seminars in Oncology","issn_l":"0093-7754","issn":["0093-7754","1532-8708"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Oncology","raw_type":"journal-article"},{"id":"pmid:21419933","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21419933","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320316008","display_name":"GIST Cancer Research Fund","ror":"https://ror.org/04py4hz40"},{"id":"https://openalex.org/F4320321317","display_name":"Gwangju Institute of Science and Technology","ror":"https://ror.org/024kbgz78"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W69309839","https://openalex.org/W110525943","https://openalex.org/W623363769","https://openalex.org/W1763457264","https://openalex.org/W1794469725","https://openalex.org/W1978588805","https://openalex.org/W2020103507","https://openalex.org/W2046336496","https://openalex.org/W2052471444","https://openalex.org/W2054251966","https://openalex.org/W2054297512","https://openalex.org/W2096843108","https://openalex.org/W2109361235","https://openalex.org/W2116137381","https://openalex.org/W2117373657","https://openalex.org/W2117624277","https://openalex.org/W2258888688","https://openalex.org/W2547550050","https://openalex.org/W4206293466","https://openalex.org/W4235712850","https://openalex.org/W6728978407"],"related_works":["https://openalex.org/W2523002110","https://openalex.org/W2092052197","https://openalex.org/W2094447499","https://openalex.org/W2278817877","https://openalex.org/W2117624277","https://openalex.org/W2890360281","https://openalex.org/W4405049912","https://openalex.org/W2029785773","https://openalex.org/W2020103507","https://openalex.org/W4401875872"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}